
Ed Jarman
9 posts

Ed Jarman
@EdJarman2
Postdoctoral researcher working on Wnt signalling in cholangiocarcinoma and liver biology at the University of Edinburgh.




In vivo modelling of patient genetic heterogeneity identifies concurrent Wnt and PI3K activity as a potent driver of invasive cholangiocarcinoma growth. biorxiv.org/cgi/content/sh… #bioRxiv




Cholangiocarcinoma is a rare disease, with only 2% of patients with metastatic disease surviving past five years. New funding is helping Cardiff University researchers to find out crucial information about this form of cancer. cardiff.ac.uk/news/view/1556…



Cholangiocarcinoma Foundation Awards $365k in Research Fellowship Grants in Largest Funding Cycle to Date💚 #curecca #cholangiocarcinoma #bileductcancer cholangiocarcinoma.org/cholangiocarci…
